Poster session
Clinical radiotherapy I

Programme

• 14:00 – 14:04 3 Min. 1 Min.

  • Eposter presentation
  • PP03.01

  Assessing treatment plan quality in DAHANCA 35: A comparative analysis of photon and proton radiotherapy

  • Camilla Panduro Nielsen (Odense / DK)

   Clinical radiotherapy, Innovative radiotherapy and medical imaging
• 14:04 – 14:08 3 Min. 1 Min.

  • Eposter presentation
  • PP03.02

  Towards an automated quality assurance workflow for optimizing computed tomography in radiotherapy

  • Niklas Lackner (Erlangen / DE)

   Clinical radiotherapy, Innovative radiotherapy and medical imaging
• 14:08 – 14:12 3 Min. 1 Min.

  • Eposter presentation
  • PP03.03

  Breast densitometry predicts outcome after radiotherapy for breast cancer

  • Alfonso Belardo (Milan / IT)

   Artificial intelligence, Clinical radiotherapy
• 14:12 – 14:16 3 Min. 1 Min.

  • Eposter presentation
  • PP03.04

  Arc-mode EPID-based picket fence for weekly QA: Sensitivity and optimum gamma

  • Antonio Gañán Mora (Madrid / ES)

   Clinical radiotherapy, Innovative radiotherapy and medical imaging
• 14:16 – 14:20 3 Min. 1 Min.

  • Eposter presentation
  • PP03.05

  Dose constraints evaluation in locally advanced cervical cancer for "classical" and EMBRACE II dose coverage probability (CoP) treatment planning approaches

  • Antonio Gañán Mora (Madrid / ES)

   Clinical radiotherapy, Innovative radiotherapy and medical imaging
• 14:20 – 14:24 3 Min. 1 Min.

  • Eposter presentation
  • PP03.06

  Dosimetric evaluation of robust intensity modulated proton therapy versus PTV-based volumetric arc radiation therapy in peripheral lung SBRT: Target coverage and normal tissue sparing comparison

  • Valeria Faccenda (Monza / IT)

   Clinical radiotherapy, Innovative radiotherapy and medical imaging
• 14:24 – 14:28 3 Min. 1 Min.

  • Eposter presentation
  • PP03.07

  Personalized contrast-enhanced 4D-CT imaging for target volume definition in abdomen SBRT

  • Valeria Faccenda (Monza / IT)

   Clinical radiotherapy, Innovative radiotherapy and medical imaging
• 14:28 – 14:32 3 Min. 1 Min.

  • Eposter presentation
  • PP03.08

  Multi-institutional Knowledge-Based (KB) benchmark for whole breast plan prediction and automated optimization

  • Dr. Sara Broggi (Milan / IT)

   Artificial intelligence, Clinical radiotherapy
• 14:32 – 14:36 3 Min. 1 Min.

  • Eposter presentation
  • PP03.09

  Simulating the oxidation process of Fe(II) to Fe(III) during water radiolysis within an irradiated Fricke solution with TOPAS-nBio and comparison to experimental data

  • Larissa Derksen (Giessen / DE)

   Clinical radiotherapy, Radiation protection
• 14:36 – 14:40 3 Min. 1 Min.

  • Eposter presentation
  • PP03.10

  Uterus dose quantification in radiotherapy for different LINACs and entities

  • Stefan Menger (Würzburg / DE)

   Clinical radiotherapy, Radiation protection
• 14:40 – 14:44 3 Min. 1 Min.

  • Eposter presentation
  • PP03.11

  Improving the quality of pediatric radiotherapy through a KBP multicentric cooperative initiative

  • Dr. Samuele Cavinato (Padua / IT)

   Clinical radiotherapy
• 14:44 – 14:48 3 Min. 1 Min.

  • Eposter presentation
  • PP03.12

  Registration pipeline to enable multi-centre voxel-based analysis using a commercially available system

  • Marcus Tyyger (Leeds / GB)

   Clinical radiotherapy, Innovative radiotherapy and medical imaging
• 14:48 – 14:52 3 Min. 1 Min.

  • Eposter presentation
  • PP03.13

  Second cancer risk for breast cancer radiotherapy: A comparison between hybrid and full VMAT techniques

  • Marina Hennet (Zurich / CH)

   Clinical radiotherapy, Radiation protection
• 14:52 – 14:56 3 Min. 1 Min.

  • Eposter presentation
  • PP03.14

  Impact of non-linear resampling to 8-bit CT for total marrow lymph-node irradiation plans

  • Monica Bianchi (Milan / IT)

   Clinical radiotherapy, Innovative radiotherapy and medical imaging
• 14:56 – 15:00 3 Min. 1 Min.

  • Eposter presentation
  • PP03.15

  Gaussian process informed voxel-based analysis shows association between radiotherapy dose and follow-up prostate specific antigen for prostate cancer

  • Dr. Jane Shortall (Manchester / GB)

   Clinical radiotherapy, Innovative radiotherapy and medical imaging